MTOR and hepatocellular carcinoma: Conversely, Zhang et al. [35] conducted a protein interaction network analysis and found that miR-184 regulates signalling pathways and cellular processes involved in HCC progression, including the cell cycle, apoptosis, and the mechanistic target of rapamycin (mTOR) pathway.